Tempus
IPO on NASDAQ: TEM
Software and genomic testing tools for personalized treatment and clinical trial matching
Funding
$1.16B
2024
Details
Headquarters
Chicago, United States
Website
Milestones
FOUNDING YEAR
2015
IPO
June 2024
Listed In
News
The latest coverage and announcements from Tempus.